Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Ophthalmology. 2020 Mar 29;127(9):1201–1210. doi: 10.1016/j.ophtha.2020.03.021

Figure 1.

Figure 1.

Distribution of office visits and diabetic macular edema (DME) treatments for follow-up study participants from baseline to 5 years after initial randomization into a 2-year clinical trial on anti-vascular endothelial growth factor (VEGF) treatment for eyes with DME (Protocol T). Each row along the vertical axis represents a timeline for a follow-up study participant. Symbols indicate office visits and DME treatments in the study eye (only one study eye per participant). Participants are ordered along the vertical axis by randomized treatment group assignment and the time of the last observed DME treatment.